Skip to main content
. 2002 Feb;127(2):360–365. doi: 10.1046/j.1365-2249.2002.01749.x

Fig. 1.

Fig. 1

levels of IL-15 in the sera (a) and in the supernatant fluids (b) of six visceral leishmaniasis patients at the moment of diagnosis (AVL) and after recovery (HVL). Healthy controls (HC). Data are reported as mean ± s.e. *P < 0·01: significantly different from healed patients and healthy controls.